Moderna, Inc. (MRNA)
Market Closed
27 Feb, 20:00
$
53. 57
+1.86
+3.6%
$
19.49B Market Cap
- P/E Ratio
- Div Yield
9,069,701 Volume
-13.23 Eps
$ 51.71
Previous Close Day Range
50.73 53.62
Year Range
22.28 55.2
Want to track MRNA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
MRNA earnings report is expected in 59 days (29 Apr 2026)
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | 0.55 |
| | | - | 0.55 |
| | | - | - |
MRNA Earnings Reports FAQ
What is the earnings per share (EPS) for MRNA?
The current EPS is -13.23.
What is the company's earnings growth rate?
Moderna, Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
The next earnings release is expected to be on 2026-04-29, based on the MRNA's typical earnings announcement schedule.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Moderna, Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for MRNA at this time, as Moderna, Inc has no recent EPS data to calculate it.
